To amend title XVIII of the Social Security Act to extend eligibility for certain payment increases for biosimilar biological products under the Medicare program.
Last action on Dec 3, 2025Referred to the House Committee on Armed Services.
Take Action
Summary
No summary available.
Lifecycle of the Bill
Introduced in House
Dec 3, 2025
Introduced in House
Dec 3, 2025
Referred to the House Committee on Armed Services.
Dec 3, 2025
